Sales of Equity Securities and Use of Proceeds
−Removed: the three months ended June 30, 2022, the Company sold 193,501 shares of common stock to accredited investors at a purchase price of
−Removed: $3.00 per share and 82,333 shares of common stock to accredited investors at a purchase price of $1.50 per share.
+Added: the nine months ended September 30, 2022, the Company sold 17,558 shares of Series A Preferred stock to accredited investors at a purchase
+Added: price of $45.00 per share and issued 95,596 shares of Series A Preferred stock for conversion of notes payable.
+Added: The Company sold 290,152
+Added: shares of common stock to accredited investors at purchase prices of $1.00 to $3.00 per share.
+Added: The Company issued 777,663 shares of common
+Added: stock for conversion of notes payable and issued 4,000 shares of common stock for services.
connection with the foregoing, the Company relied upon the exemption from registration provided under Section 4(a)(2) under the Securities
1 unchanged sentence
upon Senior Securities
+Added: Safety Disclosures
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.